We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

46 hedge funds and large institutions have $39.9M invested in Bio-Path Holdings Inc in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 15 increasing their positions, 2 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 2

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

92% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 12

32% more capital invested

Capital invested by funds: $30.2M → $39.9M (+$9.63M)

31% more funds holding

Funds holding: 3546 (+11)

Holders
46
Holders Change
+11
Holders Change %
+31.43%
% of All Funds
1.22%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
23
Increased
15
Reduced
2
Closed
12
Calls
Puts
Net Calls
Net Calls Change

BPTH Hedge Fund Activity: Q2 2016 in Review

46 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2016, worth a combined $39.9M — up 32% from $30.2M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new BPTH positions and 12 closed out — a net gain of 11 holders — while 15 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $7.56M. The largest seller was Millennium Management, exiting entirely with an estimated $1.03M sold.

  • 46 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2016, up from 35 in Q1 2016.
  • Funds reported $39.9M of Bio-Path Holdings Inc stock for Q2 2016, up 32% quarter-over-quarter.
  • 23 funds opened new Bio-Path Holdings Inc positions in Q2 2016 and 12 closed out, a net change of +11 holders.
  • The largest Bio-Path Holdings Inc buyer in Q2 2016 was Sabby Management, an estimated $7.56M added.
  • The largest Bio-Path Holdings Inc seller in Q2 2016 was Millennium Management, an estimated $1.03M sold.

Based on aggregated 13F filings for Q2 2016.